Pulmatrix

Developer of therapeutics for the treatment of respiratory diseases

placeLexington, Massachusetts, United States calendar_todayFounded 2003 groups28 employees language pulmatrix.com

Registered entities

Innovation

26 patent families (12 granted) — focus: Human necessities, Physics & computing, Operations & transport, Emerging technologies; filing pace slowing. Cited 3,356 times.

YearFilings
201310
20146
20159
20165
20175
20184
20193
20203
20212
20221
20231
20251

Investor mix

11 investors on record; lead investors include Arch Venture Partners, Polaris Partners, 5AM Ventures, Novartis Venture Fund.

Investor typeCountShare
Venture capital545%
Bank & private debt19%
Other / undisclosed545%
Coming soon